Literature DB >> 14512106

Substance abuse treatment and emergency department utilization among a cohort of HIV-infected persons with alcohol problems.

Anita Palepu1, Nicholas J Horton, Nicole Tibbetts, Kim Dukes, Seville Meli, Jeffrey H Samet.   

Abstract

We examined the association between substance abuse treatment services and emergency department (ED) utilization among participants in the HIV-Alcohol Longitudinal Cohort study of HIV-infected persons with a history of alcohol problems. A standardized questionnaire was administered to 350 subjects inquiring about demographics, substance use, use of substance abuse treatment services, and ED attendance. We operationally defined substance abuse treatment services as: stable, unstable, or none. The outcome, ED attendance, defined as presenting to an ED without subsequent hospitalization, occurred in 101 (28.8%) subjects in the past 6 months. Stable substance abuse treatment was significantly associated with lower odds of ED attendance (adjusted odds ratio; 95% CI): (0.5; 0.3-0.9). The relationship between substance abuse treatment and HIV-infected individuals' use of health care services merits additional attention. Substance abuse treatment may present an opportunity to impact health care utilization patterns of HIV-infected persons with a history of alcohol problems.

Entities:  

Mesh:

Year:  2003        PMID: 14512106     DOI: 10.1016/s0740-5472(03)00064-3

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  9 in total

Review 1.  Behavioral Interventions Targeting Alcohol Use Among People Living with HIV/AIDS: A Systematic Review and Meta-Analysis.

Authors:  Lori A J Scott-Sheldon; Kate B Carey; Blair T Johnson; Michael P Carey
Journal:  AIDS Behav       Date:  2017-11

2.  Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis.

Authors:  Alexander Y Walley; Michael Paasche-Orlow; Eugene C Lee; Shaula Forsythe; Veerappa K Chetty; Suzanne Mitchell; Brian W Jack
Journal:  J Addict Med       Date:  2012-03       Impact factor: 3.702

3.  No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use.

Authors:  Daniel Fuster; Debbie M Cheng; Donald Allensworth-Davies; Tibor P Palfai; Jeffrey H Samet; Richard Saitz
Journal:  J Gen Intern Med       Date:  2013-09-19       Impact factor: 5.128

4.  Differences in HIV risk behavior of injection drug users in New York City by health care setting.

Authors:  A K Turner; K Harripersaud; N D Crawford; A V Rivera; C M Fuller
Journal:  AIDS Care       Date:  2013-03-01

5.  Emergency department utilization among HIV-infected patients in a multisite multistate study.

Authors:  J S Josephs; J A Fleishman; P T Korthuis; R D Moore; K A Gebo
Journal:  HIV Med       Date:  2009-08-13       Impact factor: 3.180

6.  Frequent emergency department use among released prisoners with human immunodeficiency virus: characterization including a novel multimorbidity index.

Authors:  Jaimie P Meyer; Jingjun Qiu; Nadine E Chen; Gregory L Larkin; Frederick L Altice
Journal:  Acad Emerg Med       Date:  2013-01       Impact factor: 3.451

7.  Emergency department use by released prisoners with HIV: an observational longitudinal study.

Authors:  Jaimie P Meyer; Jingjun Qiu; Nadine E Chen; Gregory L Larkin; Frederick L Altice
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

8.  Episodic homelessness and health care utilization in a prospective cohort of HIV-infected persons with alcohol problems.

Authors:  Theresa W Kim; Stefan G Kertesz; Nicholas J Horton; Nicole Tibbetts; Jeffrey H Samet
Journal:  BMC Health Serv Res       Date:  2006-02-27       Impact factor: 2.655

9.  Translational methods in biostatistics: linear mixed effect regression models of alcohol consumption and HIV disease progression over time.

Authors:  Mariel M Finucane; Jeffrey H Samet; Nicholas J Horton
Journal:  Epidemiol Perspect Innov       Date:  2007-09-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.